Marino Stram & Associates’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,846
Closed -$203K 264
2021
Q2
$203K Buy
+3,846
New +$201K 0.05% 242
2019
Q2
Sell
-2,800
Closed -$124K 483
2019
Q1
$124K Hold
2,800
0.09% 101
2018
Q4
$122K Hold
2,800
0.11% 93
2018
Q3
$125K Hold
2,800
0.1% 106
2018
Q2
$112K Hold
2,800
0.1% 112
2018
Q1
$112K Hold
2,800
0.1% 116
2017
Q4
$120K Buy
+2,800
New +$129K 0.11% 99

Other funds holding SNY

Marino Stram & Associates's SNY Position: Q3 2021 in Review

Marino Stram & Associates sold out of Sanofi (SNY) in Q3 2021, closing a stake of 3,846 shares — an estimated $203K sold.

Marino Stram & Associates first reported a position in SNY in Q4 2017 and held it in 7 quarters. The position peaked at $203K in Q2 2021. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

  • Marino Stram & Associates reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
  • Marino Stram & Associates sold 3,846 Sanofi shares in Q3 2021, an estimated $203K.
  • Marino Stram & Associates first reported a position in Sanofi in Q4 2017 and held it in 7 quarters.
  • Marino Stram & Associates's Sanofi position peaked at $203K in Q2 2021.
  • 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Marino Stram & Associates's 13F filing for Q3 2021, filed 14 Oct 2021.